Furthermore, FOXO3a contributes to neuroprotection by Sirt1 in a striatal cell model of Huntington’s disease [50] and moderate FOXO3 activation was recently shown to oppose α-synuclein accumulation and proteotoxicity [51]. Here, SIRT1 is linked to Huntington disease.